Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer

詳細情報 詳細情報について

• CRID

  1361418520718445440

• DOI

  10.1007/s00280-016-2972-3

• ISSN

  14320843

  03445704

• Web Site

  http://link.springer.com/content/pdf/10.1007/s00280-016-2972-3.pdf

  http://link.springer.com/article/10.1007/s00280-016-2972-3/fulltext.html

  http://link.springer.com/content/pdf/10.1007/s00280-016-2972-3

• データソース種別

  • Crossref